top of page
Homepage Banner Ibex Biosciences 10
iStock-639481720
Lab Setting Home Page
iStock-501594440
iStock-636483828

Headquartered in North Bethesda, Maryland, Ibex Biosciences, Inc. ("Ibex") distinguishes itself in the early-stage biotech sector with its varied research and development approach.

​

Ibex is committed to discovering, validating, and developing potential health solutions through investment in unconventional projects and methodologies, irrespective of their recognition within the broader research community.

​

 

Research & Development

Ibex boasts a diverse portfolio that includes therapeutic antibodies, gene therapies, and regenerative medicine programs.

​

We are proud of our proven capacity to discover and validate potential therapies from scratch, thus eliminating the need for external technology acquisitions or in-licensing.

 

Our accomplishments are underscored by a series of in-vivo studies, which have delivered remarkable efficacy against a range of challenging medical conditions.

Latest News 
patent photo.jpg

Ibex Announces New Patent Pending

​

Ibex announces the patent publication of Antibodies targeted to CD147

Ibex Biosciences awarded as a Top 10 Biotech Startup of 2022

​

Ibex recognized as an Innovative Biotech Company

bottom of page